A Rat Model of Neonatal Candidiasis Demonstrates the Importance of Lipases as Virulence Factors for Candida albicans and Candida parapsilosis

Mycopathologia

Volumn 172, Issue 3, 2011, Pages 169-178

  Trofa, David ^a   Soghier, Lamia ^a   Long, Christina ^a   Nosanchuk, Joshua D ^a   Gacser, Attila ^b   Goldman, David L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Candida; Infection model; Lipases; Rat

Indexed keywords

TRIACYLGLYCEROL LIPASE; VIRULENCE FACTOR;

ANIMAL; ARTICLE; CANDIDA; CANDIDIASIS; DISEASE MODEL; ENZYMOLOGY; FEMALE; GENE INACTIVATION; GENETICS; MALE; METABOLISM; MICROBIOLOGY; NEWBORN; PATHOGENICITY; RAT; RODENT DISEASE; SPRAGUE DAWLEY RAT; SURVIVAL; VIRULENCE;

ANIMALS; ANIMALS, NEWBORN; CANDIDA; CANDIDIASIS; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCKOUT TECHNIQUES; LIPASE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RODENT DISEASES; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; RATTUS;

EID: 79960574755     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9429-3     Document Type: Article

References (36)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39: 309-17.
2. Girmenia C, Martino P, De Bernardis F, Gentile G, Boccanera M, Monaco M, Antonucci G, Cassone A. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis. 1996; 23: 506-14.
3. Levin AS, Costa SF, Mussi NS, Basso M, Sinto SI, Machado C, Geiger DC, Villares MC, Schreiber AZ, Barone AA, Branchini ML. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis. 1998; 30: 243-9.
4. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 1998; 26: 1086-8.
5. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis. 1998; 26: 642-5.
6. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics. 2005; 116: 61-7.
7. Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008; 21: 606-25.
8. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003; 37: 634-43.
9. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004; 23: 635-41.
10. Zaoutis T. Candidemia in children. Curr Med Res Opin. 2010; 26: 1761-8.
11. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics. 1984; 73: 144-52.
12. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002; 110: 285-91.
13. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001; 345: 1660-6.
14. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L, Dave VA, Nafday S, Brion LP. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics. 2006; 117: 1243-52.
15. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Candida parapsilosis infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2007; 92: F127-9.
16. Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics. 2006; 117: 1680-7.
17. Feja KN, Wu F, Roberts K, Loughrey M, Nesin M, Larson E, Della-Latta P, Haas J, Cimiotti J, Saiman L. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr. 2005; 147: 156-61.
18. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000; 19: 319-24.
19. Schmidt A. Systemic candidiasis in Sprague-Dawley rats. J Med Vet Mycol. 1996; 34: 99-104.
20. Gacser A, Trofa D, Schafer W, Nosanchuk JD. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest. 2007; 117: 3049-58.
21. Gacser A, Stehr F, Kroger C, Kredics L, Schafer W, Nosanchuk JD. Lipase 8 affects the pathogenesis of Candida albicans. Infect Immun. 2007; 75: 4710-8.
22. Goldman DL, Casadevall A, Cho Y, Lee SC. Cryptococcus neoformans meningitis in the rat. Lab Invest. 1996; 75: 759-70.
23. Konno N, Ishii M, Nagai A, Watanabe T, Ogasawara A, Mikami T, Matsumoto T. Mechanism of Candida albicans transformation in response to changes of pH. Biol Pharm Bull. 2006; 29: 923-6.
24. Destin KG, Linden JR, Laforce-Nesbitt SS, Bliss JM. Oxidative burst and phagocytosis of neonatal neutrophils confronting Candida albicans and Candida parapsilosis. Early Hum Dev. 2009; 85: 531-5.
25. Witek-Janusek L, Shareef MJ, Mathews HL. Reduced lymphocyte-mediated antifungal capacity in high-risk infants. J Infect Dis. 2002; 186: 129-33.
26. Gollin G, Marks WH. Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NEC. J Pediatr Surg. 1993; 28: 367-70.
27. Frank L. Prenatal dexamethasone treatment improves survival of newborn rats during prolonged high O2 exposure. Pediatr Res. 1992; 32: 215-21.
28. Toropainen M, Kayhty H, Saarinen L, Rosenqvist E, Hoiby EA, Wedege E, Michaelsen T, Makela PH. The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci. Vaccine. 1999; 17: 2677-89.
29. Pope LM, Cole GT, Guentzel MN, Berry LJ. Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge. Infect Immun. 1979; 25: 702-7.
30. Brzozowski T, Zwolinska-Wcislo M, Konturek PC, Kwiecien S, Drozdowicz D, Konturek SJ, Stachura J, Budak A, Bogdal J, Pawlik WW, Hahn EG. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol. 2005; 40: 286-96.
31. Kelly EJ, Newell SJ, Brownlee KG, Primrose JN, Dear PR. Gastric acid secretion in preterm infants. Early Hum Dev. 1993; 35: 215-20.
32. Nguyen LN, Trofa D, Nosanchuk JD. Fatty acid synthase impacts the pathobiology of Candida parapsilosis in vitro and during mammalian infection. PLoS ONE. 2009; 4: e8421.
33. Schofield DA, Westwater C, Warner T, Balish E. Differential Candida albicans lipase gene expression during alimentary tract colonization and infection. FEMS Microbiol Lett. 2005; 244: 359-65.
34. Stehr F, Felk A, Gacser A, Kretschmar M, Mahnss B, Neuber K, Hube B, Schafer W. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res. 2004; 4: 401-8.
35. Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet. 1984; 198: 179-82.
36. Gacser A, Salomon S, Schafer W. Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker. FEMS Microbiol Lett. 2005; 245: 117-21.